Life Corp
TSE:8194
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 676.584
2 567
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Life Corp
Cash & Cash Equivalents
Life Corp
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Life Corp
TSE:8194
|
Cash & Cash Equivalents
ÂĄ36.2B
|
CAGR 3-Years
71%
|
CAGR 5-Years
17%
|
CAGR 10-Years
10%
|
|
|
Seven & i Holdings Co Ltd
TSE:3382
|
Cash & Cash Equivalents
ÂĄ709.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-4%
|
|
|
Lawson Inc
TSE:2651
|
Cash & Cash Equivalents
ÂĄ506.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
17%
|
|
|
Yaoko Co Ltd
TSE:8279
|
Cash & Cash Equivalents
ÂĄ44.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
|
|
Kobe Bussan Co Ltd
TSE:3038
|
Cash & Cash Equivalents
ÂĄ120.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
|
|
A
|
Arcs Co Ltd
TSE:9948
|
Cash & Cash Equivalents
ÂĄ93.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Life Corp
Glance View
Life Corp began its journey in the early 2000s, emerging from a small start-up to a notable player in the healthcare and wellness sector. Initially focusing on developing innovative medical devices, the company identified a niche in integrated healthcare solutions. It invested heavily in research and technology, establishing partnerships with leading hospitals and clinics to provide state-of-the-art diagnostic equipment. This strategic collaboration not only broadened its market reach but also ensured a steady revenue stream from the leasing and maintenance of its technology. Over the years, Life Corp expanded its portfolio, delving into telemedicine platforms that have become increasingly popular. The company's business model revolves around coupling its hardware offerings with consistent customer support services, creating a robust ecosystem that clients rely on. By streamlining operations through digital solutions, Life Corp has successfully tapped into recurring income. The seamless integration of software with medical applications provides clients with real-time data, optimizing their healthcare management processes. This dual-source income strategy, combining product sales with subscription-based services, has fueled Life Corp’s sustainable growth, enabling it to secure a stable foothold in an ever-evolving industry.
See Also
What is Life Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
36.2B
JPY
Based on the financial report for Aug 31, 2025, Life Corp's Cash & Cash Equivalents amounts to 36.2B JPY.
What is Life Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
10%
Over the last year, the Cash & Cash Equivalents growth was 25%. The average annual Cash & Cash Equivalents growth rates for Life Corp have been 71% over the past three years , 17% over the past five years , and 10% over the past ten years .